Efficacy and Safety of Setmelanotide in Acquired Hypothalamic Obesity: Results from a Double- Blind, Multicenter, Placebo-Controlled, Randomized Phase 3 Trial July 12, 2025, 2:00 PM - 2:15 PM PT Christian Roth, M.D., Seattle Children's Research Institute, will present a poster detailing exit interviews gathered from 30 patients or caregivers located in the US with acquired hypothalamic obesity who participated in the Phase 3 TRANSCEND trial. Experiences and Observations with Acquired Hypothalamic Obesity: A ...